India Tumor Board Decision AI Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Tumor Board Decision AI Market was valued at USD 589.0 million in 2025 and is projected to reach USD 1,062.96 million by 2032, growing at a CAGR of approximately 8.8% during 2026–2032.
India Tumor Board Decision AI Market Highlights
| Report Metric | Details |
| Report Name | India Tumor Board Decision AI Market |
| Market Size 2025 | USD 589.0 million |
| Market Size 2032 | USD 1,062.96 million |
| Absolute Growth 2025–2032 | USD 473.96 million |
| CAGR 2026–2032 | 8.8% |
| Peak Annual Growth | 10.7% in 2030 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading AI Capability, 2025 | Treatment Planning AI (49% share) |
| Leading Data Input Source, 2025 | EHR + Genomic Data (45% share) |
| Leading Use Case, 2025 | Oncology Board Support (43% share) |
| Leading End User, 2025 | Cancer Centers (43% share) |
| Fastest-Growing AI Capability | Prognosis Prediction AI (11.6% CAGR) |
| Fastest-Growing Use Case | Complex Case Review (11.2% CAGR) |
| Fastest-Growing End User | Research Hospitals (10.5% CAGR) |
| Growing Sector | Oncology |
| Key End Users | Cancer Centers, Hospitals, Research Hospitals, Tumor Boards |
India Tumor Board Decision AI Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Year by year, the estimates below pair each growth rate with the development that shaped it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 6.4 | The market experienced initial growth as cancer treatment centers expanded their capabilities. |
| 2023 | 7.2 | Demand increased due to the National Cancer Control Programme promoting AI technologies in oncology. |
| 2024 | 9.5 | The market saw accelerated growth driven by rising cancer incidence and treatment needs. |
| 2025 | 6.5 | Growth slowed as the National Health Mission's initiatives began to take effect. |
| 2026 | 6.4 | A further slowdown is expected as the Digital Health Mission integrates new technologies. |
| 2027 | 9.9 | Growth is projected to rebound with increased investments in AI technologies for cancer care. |
| 2028 | 9.4 | A slight slowdown is anticipated as the market adjusts to new technology integrations. |
| 2029 | 8.0 | Demand will continue to grow, driven by the increasing number of cancer cases. |
| 2030 | 10.7 | The market is expected to peak with advancements in AI applications for oncology. |
| 2031 | 9.0 | Growth will slow as the market matures and the National Cancer Control Programme evolves. |
| 2032 | 8.2 | A further slowdown is projected as the market reaches a stable growth phase. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Tumor Board Decision AI Market Synopsis
The Tumor Board Decision AI in India incorporates AI technologies that aid oncology professionals in making informed decisions about cancer treatment. This technology enhances treatment planning, predicts prognosis, and simplifies complex case reviews. The market is expanding due to over 1.5 million new cancer cases reported each year, along with the growth of cancer treatment centres. Government initiatives such as the National Cancer Control Programme are driving demand for advanced AI solutions in oncology, improving patient care and management.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising cancer incidence drives demand for advanced treatment solutions. | Driver | High | Oncology Board Support |
| Increasing investment in AI technologies enhances treatment planning capabilities. | Driver | High | Treatment Planning AI |
| Growing demand for personalized healthcare solutions presents opportunities for AI integration. | Opportunity | High | Prognosis Prediction AI |
| The expansion of cancer treatment centers creates a need for advanced decision-making tools. | Opportunity | High | Cancer Centers |
| Limited awareness of AI benefits in oncology may hinder adoption rates. | Restraint | Medium | Diagnostic Assistance |
| High initial costs of AI technologies can deter smaller facilities from investing. | Restraint | Medium | Tumor Boards |
| The market faces challenges in integrating AI with existing healthcare systems. | Challenge | High | Research Hospitals |
| Regulatory hurdles may delay the approval of new AI technologies in oncology. | Challenge | Medium | Cancer Centers |
Evaluation of Drivers in India Tumor Board Decision AI Market (2026–2032)
The table below links each growth driver to the segment it affects and the evidence for it.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing cancer cases necessitate advanced treatment planning solutions. | Oncology Board Support | With over 1.5 million new cancer cases annually, treatment centers require effective decision-making tools. |
| Rising investments in AI technologies improve diagnostic capabilities. | Treatment Planning AI | The Indian healthcare sector is projected to reach ₹8.6 trillion, driving demand for AI solutions. |
| Government initiatives promote technology adoption in cancer care. | Prognosis Prediction AI | The National Cancer Control Programme emphasizes early detection and treatment, boosting AI integration. |
| Growing patient populations increase the need for personalized treatment solutions. | Cancer Centers | As cancer treatment centers expand, they seek advanced AI tools for better patient management. |
| Collaboration between healthcare providers and technology developers drives innovation. | Diagnostic Assistance | The Indian Council of Medical Research supports AI initiatives, encouraging integration in oncology. |
With over 1.5 million new cancer cases reported annually, treatment centers are seeking advanced decision-making tools. The healthcare sector is projected to reach ₹8.6 trillion, supporting the adoption of AI solutions. Collaborations between healthcare providers and technology developers are enhancing innovation and improving diagnostic capabilities.
Evaluation of Restraints in India Tumor Board Decision AI Market
The table below lists the restraints and the evidence behind each.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited awareness of AI benefits may hinder adoption rates. | Diagnostic Assistance | Many healthcare professionals remain unaware of how AI can improve treatment outcomes, slowing integration. |
| High initial costs of AI technologies can deter smaller facilities from investing. | Tumor Boards | Smaller cancer treatment centers may struggle to afford advanced AI solutions, limiting widespread use. |
| Regulatory hurdles can delay the approval of new AI technologies in oncology. | Research Hospitals | Complex approval processes may slow the introduction of new AI applications in cancer care. |
| Integration challenges with existing healthcare systems can impede AI adoption. | Cancer Centers | Many facilities face difficulties in aligning new AI technologies with current workflows and systems. |
| Data privacy concerns may limit the sharing of patient information for AI applications. | Oncology Board Support | Strict regulations on patient data can hinder the effectiveness of AI in treatment planning. |
India Tumor Board Decision AI Market Challenges
The India Tumor Board Decision AI market encounters several practical problems, with competition being a primary concern. Many cancer treatment centers are adopting diverse AI solutions, which can reduce market share for existing providers. Supply chain issues arise, as advanced AI technologies often rely on imported components, causing delays in implementation for hospitals. A shortage of skilled professionals complicates the integration of this technology in oncology, as the demand for trained experts exceeds the available workforce, with only 1,000 cancer treatment centers currently equipped to handle these innovations. Regulatory challenges also hinder progress, as compliance with standards like ISO 9001:2015 can slow down the deployment of new AI systems in healthcare settings.
Trends in the India Tumor Board Decision AI Market
The trends below show where the India Tumor Board Decision AI Market is heading.
- Shift Towards AI-Driven Treatment Planning: In 2022, cancer treatment centres increasingly adopted AI-driven solutions for treatment planning, with 45% of facilities implementing such technologies. This shift improves decision-making and patient outcomes.
- Growing Focus on Personalized Cancer Care: Cancer centres are prioritising personalised treatment plans, with 49% of facilities using AI for tailored patient management. This trend reflects the demand for more effective treatment strategies.
- Increased Integration of Genomic Data: Since 2021, the use of EHR and genomic data in AI applications has risen, with 45% of cancer centres adopting these technologies. This integration improves diagnostic accuracy and treatment efficacy.
- Expansion of AI in Research Hospitals: Research hospitals have seen a 10.5% growth in AI applications since 2026, driven by the need for advanced research tools. This trend supports innovative cancer treatment strategies.
Investment Opportunities in the India Tumor Board Decision AI Market
Below are the investment opportunities with the strongest case in the India Tumor Board Decision AI Market.
- Supply of Advanced AI Solutions: With the Indian healthcare sector projected to reach ₹8.6 trillion, there is a growing opportunity to supply advanced AI solutions for cancer treatment centres, improving decision-making capabilities.
- Investment in AI-Driven Prognosis Tools: Cancer treatment centres are increasingly seeking AI-driven prognosis tools, creating opportunities for suppliers to develop effective solutions that meet this demand.
- Development of AI for Complex Case Reviews: The need for efficient case prioritisation presents an opportunity to develop AI solutions tailored for complex case reviews, particularly in busy cancer treatment centres.
- Integration of Digital Health Solutions: The National Digital Health Mission aims to integrate digital health solutions, presenting opportunities for companies to collaborate with healthcare providers in implementing AI technologies.
Government Initiatives in the India Tumor Board Decision AI Market
The Digital Health Mission, launched in 2022, promotes the integration of digital technologies in healthcare, including AI applications in oncology. This initiative builds on the National Cancer Control Programme established in 2020, which focuses on prevention, early detection, and treatment of cancer, improving the framework for AI implementation in cancer care.
In 2021, the Indian government allocated ₹1,000 crores for cancer control initiatives, administered by the Ministry of Health and Family Welfare. This funding supports various programmes aimed at improving cancer care accessibility and promoting the use of technology in treatment, including AI solutions.
Future Insight of the India Tumor Board Decision AI Market
The India Tumor Board Decision AI market is expected to undergo notable changes by 2032, primarily due to the National Digital Health Mission's push for integrated digital health solutions. The Indian government’s allocation of ₹1,000 crores for cancer control initiatives will likely support advancements in AI technologies, improving treatment planning and patient outcomes. As the National Cancer Control Programme emphasises early detection, AI will play a vital role in streamlining processes and enhancing efficiency in cancer care. Collaboration between the Ministry of Electronics and Information Technology and healthcare providers will facilitate the adoption of these technologies.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By AI Capability – Treatment Planning AI Dominated, Prognosis Prediction AI Expected to Grow Fastest
According to Vasudha, AM at 6Wresearch, in 2025, Treatment Planning AI led the ai capability split with a 49% share. Treatment Planning AI captures the largest share in the India Tumor Board Decision AI Market because it is essential for developing personalised treatment plans for cancer patients. Oncology professionals rely on this technology to navigate the complexities of over 1.5 million new cancer cases reported annually. Prognosis Prediction AI is set to record the highest CAGR in this split, 11.6% over 2026–2032. Prognosis Prediction AI is experiencing rapid growth as it assists in estimating patient outcomes based on historical data, which is vital for managing the increasing number of cancer cases. The support from the Indian Council of Medical Research for AI in oncology will further enhance this segment's expansion. Suppliers should focus on enhancing AI capabilities to meet the growing demand for effective treatment planning and prognosis prediction.
By Data Input Source – EHR + Genomic Data Dominated and Is Expected to Record the Fastest Growth
EHR + Genomic Data accounted for a 45% market share by data input source in 2025. EHR + Genomic Data holds the largest share in the market as it provides comprehensive patient information crucial for informed decision-making in cancer treatment. This integration is vital for the approximately 1,000 cancer treatment centres in India, ensuring they have access to the most relevant data. The same category is also set to grow fastest, at a CAGR of 10.3% during 2026–2032. EHR + Genomic Data is also the fastest-growing segment as healthcare providers increasingly recognise the importance of combining electronic health records with genomic information for better patient outcomes. This trend aligns with government initiatives that promote advanced digital health solutions. Buyers must invest in robust data management systems to effectively utilise EHR and genomic data for enhanced patient care.
By Use Case – Oncology Board Support Dominated, Complex Case Review Expected to Grow Fastest
Oncology Board Support took a 43% share of use case in 2025, more than any other category. Oncology Board Support leads the market share as it significantly enhances the decision-making process in tumour boards, which are essential for collaborative treatment planning. Given the high incidence of cancer cases in India, efficient discussions among oncology professionals are critical. Over 2026–2032, Complex Case Review is expected to post the fastest growth, at a CAGR of 11.2%. Complex Case Review is the fastest-growing use case, as it allows for thorough evaluations of complicated cancer cases that require multi-disciplinary input. The rising complexity of cancer treatments drives the demand for advanced solutions to support these reviews. Providers should develop tailored solutions that cater to the specific needs of oncology boards and complex case reviews to capture market opportunities.
By End User – Cancer Centers Dominated, Research Hospitals Expected to Grow Fastest
Cancer Centers held a 43% share of the India Tumor Board Decision AI Market by end user in 2025. Cancer Centers dominate the market share as the primary end-users of Tumor Board Decision AI technology, using it to improve patient management and treatment outcomes. With a robust network of around 1,000 centres in India, their demand for AI solutions is substantial. Research Hospitals are projected to grow fastest, at a CAGR of 10.5% during 2026–2032. Research Hospitals are the fastest-growing end-user segment, leveraging AI technology for advanced research and clinical trials to enhance cancer treatment methodologies. The increasing focus on research in oncology fuels this growth as these institutions seek cutting-edge solutions. Suppliers should concentrate on research hospitals with tailored AI solutions that address their advanced research and clinical trial needs.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Tumor Board Decision AI Market Outlook
- Market Size of India Tumor Board Decision AI Market, 2025
- Forecast of India Tumor Board Decision AI Market, 2032
- Historical Data and Forecast of India Tumor Board Decision AI Revenues & Volume for the Period 2022 - 2032F
- India Tumor Board Decision AI Market Trend Evolution
- India Tumor Board Decision AI Market Drivers and Challenges
- India Tumor Board Decision AI Price Trends
- India Tumor Board Decision AI Porter's Five Forces
- India Tumor Board Decision AI Industry Life Cycle
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By AI Capability for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Treatment Planning AI for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Prognosis Prediction AI for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Case Prioritization AI for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Diagnostic Assistance for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Data Input Source for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Pathology + Radiology for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By EHR + Genomic Data for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Clinical Summaries for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Histology/Imaging for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Use Case for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Oncology Board Support for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Patient Risk Assessment for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Scheduling Discussions for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Complex Case Review for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Cancer Centers for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Tumor Boards for the Period 2022 - 2032F
- Historical Data and Forecast of India Tumor Board Decision AI Market Revenues & Volume By Research Hospitals for the Period 2022 - 2032F
- India Tumor Board Decision AI Import Export Trade Statistics
- Market Opportunity Assessment By AI Capability
- Market Opportunity Assessment By Data Input Source
- Market Opportunity Assessment By Use Case
- Market Opportunity Assessment By End User
- India Tumor Board Decision AI Top Companies Market Share
- India Tumor Board Decision AI Competitive Benchmarking By Technical and Operational Parameters
- India Tumor Board Decision AI Company Profiles
- India Tumor Board Decision AI Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments.
By AI Capability
- Treatment Planning AI
- Prognosis Prediction AI
- Case Prioritization AI
- Diagnostic Assistance
By Data Input Source
- Pathology + Radiology
- EHR + Genomic Data
- Clinical Summaries
- Histology/Imaging
By Use Case
- Oncology Board Support
- Patient Risk Assessment
- Scheduling Discussions
- Complex Case Review
By End User
- Cancer Centers
- Hospitals
- Tumor Boards
- Research Hospitals
